Levodopa (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Levodopa" in Indonesian language version.

Last modified: 22:44:58, 12 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank Indonesian rank

3030nih.gov

5^th place

6^th place

2121doi.org

2^nd place

54books.google.com

3^rd place

4^th place

44archive.org

6^th place

3^rd place

33web.archive.org

1^st place

33hdl.handle.net

66^th place

122^nd place

32drugs.com

529^th place

177^th place

22semanticscholar.org

15^th place

26^th place

11webmd.com

2,056^th place

872^nd place

11laskerfoundation.org

low place

11inbrija.com

low place

11acorda.com

low place

11fda.gov

470^th place

343^rd place

acorda.com (Global: low place; Indonesian: low place)

ir.acorda.com

"Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)". ir.acorda.com (dalam bahasa Canadian English). Diarsipkan dari asli tanggal 27 Desember 2018. Diakses tanggal 14 Februari 2019.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

archive.org (Global: 6^th place; Indonesian: 3^rd place)

Cotzias GC, Papavasiliou PS, Gellene R (Juli 1969). "L-dopa in parkinson's syndrome". The New England Journal of Medicine. 281 (5): 272. doi:10.1056/NEJM196907312810518. PMID 5791298.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cotzias GC (Maret 1968). "L-Dopa for Parkinsonism". The New England Journal of Medicine. 278 (11): 630. doi:10.1056/nejm196803142781127. PMID 5637779.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Hardebo JE, Owman C (Juli 1980). "Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface". Annals of Neurology. 8 (1): 1–31. doi:10.1002/ana.410080102. PMID 6105837. S2CID 22874032.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brown AS, Gershon S (1993). "Dopamine and depression". J Neural Transm Gen Sect. 91 (2–3): 75–109. doi:10.1007/BF01245227. PMID 8099801.

books.google.com (Global: 3^rd place; Indonesian: 4^th place)

Simuni T, Hurtig H (2008). "Levadopa: A Pharmacologic Miracle Four Decades Later". Dalam Factor SA, Weiner WJ (ed.). Parkinson's Disease: Diagnosis and Clinical Management. Demos Medical Publishing. ISBN 978-1-934559-87-1 – via Google eBook.
Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Medpharm Scientific Publishers. hlm. 699. ISBN 978-3-88763-101-7. Diakses tanggal 28 September 2024.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. hlm. 54. ISBN 978-1-4757-2085-3. Diakses tanggal 28 September 2024.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. hlm. 164. ISBN 978-94-011-4439-1. Diakses tanggal 28 September 2024.{{cite book}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

Howard ST, Hursthouse MB, Lehmann CW, Poyner EA (1995). "Experimental and theoretical determination of electronic properties in Ldopa". Acta Crystallogr. B. 51: 328–337. doi:10.1107/S0108768194011407.
Ehringer H, Hornykiewicz O (Desember 1960). "[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]". Klinische Wochenschrift. 38 (24): 1236–9. doi:10.1007/BF01485901. PMID 13726012. S2CID 32896604.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cotzias GC, Papavasiliou PS, Gellene R (Juli 1969). "L-dopa in parkinson's syndrome". The New England Journal of Medicine. 281 (5): 272. doi:10.1056/NEJM196907312810518. PMID 5791298.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cotzias GC (Maret 1968). "L-Dopa for Parkinsonism". The New England Journal of Medicine. 278 (11): 630. doi:10.1056/nejm196803142781127. PMID 5637779.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Hardebo JE, Owman C (Juli 1980). "Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface". Annals of Neurology. 8 (1): 1–31. doi:10.1002/ana.410080102. PMID 6105837. S2CID 22874032.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Ovallath S, Sulthana B (2017). "Levodopa: History and Therapeutic Applications". Annals of Indian Academy of Neurology. 20 (3): 185–189. doi:10.4103/aian.AIAN_241_17. PMC 5586109. PMID 28904446.
Cohen PA, Avula B, Katragunta K, Khan I (Oktober 2022). "Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database". JAMA Neurology. 79 (10): 1085–1086. doi:10.1001/jamaneurol.2022.2184. PMC 9361182. PMID 35939305.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Livingston C, Monroe-Duprey L (April 2024). "A Review of Levodopa Formulations for the Treatment of Parkinson's Disease Available in the United States". J Pharm Pract. 37 (2): 485–494. doi:10.1177/08971900221151194. PMID 36704966.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Nakmode DD, Day CM, Song Y, Garg S (Mei 2023). "The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems". Pharmaceutics. 15 (5): 1503. doi:10.3390/pharmaceutics15051503. PMC 10223383. PMID 37242745.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fabbri M, Barbosa R, Rascol O (April 2023). "Off-time Treatment Options for Parkinson's Disease". Neurol Ther. 12 (2): 391–424. doi:10.1007/s40120-022-00435-8. PMC 10043092. PMID 36633762.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lees A, Tolosa E, Stocchi F, Ferreira JJ, Rascol O, Antonini A, Poewe W (Januari 2023). "Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach". Expert Rev Neurother. 23 (1): 15–24. doi:10.1080/14737175.2023.2176220. hdl:10451/56313. PMID 36729395.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Doggrell SA (2023). "Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?". Expert Opin Drug Deliv. 20 (9): 1189–1199. doi:10.1080/17425247.2023.2253146. hdl:10072/425143. PMID 37634938.
Urso D, Chaudhuri KR, Qamar MA, Jenner P (November 2020). "Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies". CNS Drugs. 34 (11): 1149–1163. doi:10.1007/s40263-020-00769-7. PMID 33146817.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cacciatore I, Ciulla M, Marinelli L, Eusepi P, Di Stefano A (April 2018). "Advances in prodrug design for Parkinson's disease". Expert Opin Drug Discov. 13 (4): 295–305. doi:10.1080/17460441.2018.1429400. PMID 29361853.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R (Desember 2017). "Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease". Molecules. 23 (1): 40. doi:10.3390/molecules23010040. PMC 5943940. PMID 29295587.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M (Mei 2016). "Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology". Brain. 139 (Pt 5): 1325–1347. doi:10.1093/brain/aww050. PMC 5839596. PMID 27189581.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brown AS, Gershon S (1993). "Dopamine and depression". J Neural Transm Gen Sect. 91 (2–3): 75–109. doi:10.1007/BF01245227. PMID 8099801.
Webber HE, Lopez-Gamundi P, Stamatovich SN, de Wit H, Wardle MC (Januari 2021). "Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults". Neurosci Biobehav Rev. 120: 123–158. doi:10.1016/j.neubiorev.2020.11.004. PMC 7855845. PMID 33202256.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Zénon A, Devesse S, Olivier E (September 2016). "Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost". J Neurosci. 36 (37): 9516–9525. doi:10.1523/JNEUROSCI.4467-15.2016. PMC 6601940. PMID 27629704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Salamone JD, Correa M (Januari 2024). "The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine". Annu Rev Psychol. 75: 1–32. doi:10.1146/annurev-psych-020223-012208. hdl:10234/207207. PMID 37788571.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS (Maret 2016). "Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration". The American Journal of Medicine. 129 (3): 292–8. doi:10.1016/j.amjmed.2015.10.015. PMC 4841631. PMID 26524704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

drugs.com (Global: 529^th place; Indonesian: 177^th place)

"Levodopa Use During Pregnancy". Drugs.com. 12 Juli 2019. Diakses tanggal 27 September 2020.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Levodopa (International database)". Drugs.com. 2 September 2024. Diakses tanggal 28 September 2024.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

fda.gov (Global: 470^th place; Indonesian: 343^rd place)

accessdata.fda.gov

"Drugs@FDA: FDA-Approved Drugs". accessdata.fda.gov. Diarsipkan dari asli tanggal November 4, 2016. Diakses tanggal 28 September 2024.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

Lees A, Tolosa E, Stocchi F, Ferreira JJ, Rascol O, Antonini A, Poewe W (Januari 2023). "Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach". Expert Rev Neurother. 23 (1): 15–24. doi:10.1080/14737175.2023.2176220. hdl:10451/56313. PMID 36729395.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Doggrell SA (2023). "Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?". Expert Opin Drug Deliv. 20 (9): 1189–1199. doi:10.1080/17425247.2023.2253146. hdl:10072/425143. PMID 37634938.
Salamone JD, Correa M (Januari 2024). "The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine". Annu Rev Psychol. 75: 1–32. doi:10.1146/annurev-psych-020223-012208. hdl:10234/207207. PMID 37788571.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

inbrija.com (Global: low place; Indonesian: low place)

"Inbrija Prescribing Information" (PDF). Diakses tanggal 14 Februari 2019.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

laskerfoundation.org (Global: low place; Indonesian: low place)

"Lasker Award". 1969. Diarsipkan dari asli tanggal 5 Januari 2016.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link), retrieved 1 April 2013

nih.gov (Global: 5^th place; Indonesian: 6^th place)

pubmed.ncbi.nlm.nih.gov

Ehringer H, Hornykiewicz O (Desember 1960). "[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]". Klinische Wochenschrift. 38 (24): 1236–9. doi:10.1007/BF01485901. PMID 13726012. S2CID 32896604.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Birkmayer W, Hornykiewicz O (November 1961). "[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]". Wiener Klinische Wochenschrift. 73: 787–8. PMID 13869404.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cotzias GC, Papavasiliou PS, Gellene R (Juli 1969). "L-dopa in parkinson's syndrome". The New England Journal of Medicine. 281 (5): 272. doi:10.1056/NEJM196907312810518. PMID 5791298.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cotzias GC (Maret 1968). "L-Dopa for Parkinsonism". The New England Journal of Medicine. 278 (11): 630. doi:10.1056/nejm196803142781127. PMID 5637779.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Hardebo JE, Owman C (Juli 1980). "Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface". Annals of Neurology. 8 (1): 1–31. doi:10.1002/ana.410080102. PMID 6105837. S2CID 22874032.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Ovallath S, Sulthana B (2017). "Levodopa: History and Therapeutic Applications". Annals of Indian Academy of Neurology. 20 (3): 185–189. doi:10.4103/aian.AIAN_241_17. PMC 5586109. PMID 28904446.
Cohen PA, Avula B, Katragunta K, Khan I (Oktober 2022). "Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database". JAMA Neurology. 79 (10): 1085–1086. doi:10.1001/jamaneurol.2022.2184. PMC 9361182. PMID 35939305.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Livingston C, Monroe-Duprey L (April 2024). "A Review of Levodopa Formulations for the Treatment of Parkinson's Disease Available in the United States". J Pharm Pract. 37 (2): 485–494. doi:10.1177/08971900221151194. PMID 36704966.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Nakmode DD, Day CM, Song Y, Garg S (Mei 2023). "The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems". Pharmaceutics. 15 (5): 1503. doi:10.3390/pharmaceutics15051503. PMC 10223383. PMID 37242745.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fabbri M, Barbosa R, Rascol O (April 2023). "Off-time Treatment Options for Parkinson's Disease". Neurol Ther. 12 (2): 391–424. doi:10.1007/s40120-022-00435-8. PMC 10043092. PMID 36633762.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Lees A, Tolosa E, Stocchi F, Ferreira JJ, Rascol O, Antonini A, Poewe W (Januari 2023). "Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach". Expert Rev Neurother. 23 (1): 15–24. doi:10.1080/14737175.2023.2176220. hdl:10451/56313. PMID 36729395.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Doggrell SA (2023). "Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson's disease: is it an improvement on other delivery?". Expert Opin Drug Deliv. 20 (9): 1189–1199. doi:10.1080/17425247.2023.2253146. hdl:10072/425143. PMID 37634938.
Urso D, Chaudhuri KR, Qamar MA, Jenner P (November 2020). "Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies". CNS Drugs. 34 (11): 1149–1163. doi:10.1007/s40263-020-00769-7. PMID 33146817.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Cacciatore I, Ciulla M, Marinelli L, Eusepi P, Di Stefano A (April 2018). "Advances in prodrug design for Parkinson's disease". Expert Opin Drug Discov. 13 (4): 295–305. doi:10.1080/17460441.2018.1429400. PMID 29361853.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R (Desember 2017). "Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease". Molecules. 23 (1): 40. doi:10.3390/molecules23010040. PMC 5943940. PMID 29295587.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M (Mei 2016). "Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology". Brain. 139 (Pt 5): 1325–1347. doi:10.1093/brain/aww050. PMC 5839596. PMID 27189581.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brown AS, Gershon S (1993). "Dopamine and depression". J Neural Transm Gen Sect. 91 (2–3): 75–109. doi:10.1007/BF01245227. PMID 8099801.
Webber HE, Lopez-Gamundi P, Stamatovich SN, de Wit H, Wardle MC (Januari 2021). "Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults". Neurosci Biobehav Rev. 120: 123–158. doi:10.1016/j.neubiorev.2020.11.004. PMC 7855845. PMID 33202256.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Zénon A, Devesse S, Olivier E (September 2016). "Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost". J Neurosci. 36 (37): 9516–9525. doi:10.1523/JNEUROSCI.4467-15.2016. PMC 6601940. PMID 27629704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Salamone JD, Correa M (Januari 2024). "The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine". Annu Rev Psychol. 75: 1–32. doi:10.1146/annurev-psych-020223-012208. hdl:10234/207207. PMID 37788571.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS (Maret 2016). "Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration". The American Journal of Medicine. 129 (3): 292–8. doi:10.1016/j.amjmed.2015.10.015. PMC 4841631. PMID 26524704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

ncbi.nlm.nih.gov

Ovallath S, Sulthana B (2017). "Levodopa: History and Therapeutic Applications". Annals of Indian Academy of Neurology. 20 (3): 185–189. doi:10.4103/aian.AIAN_241_17. PMC 5586109. PMID 28904446.
Cohen PA, Avula B, Katragunta K, Khan I (Oktober 2022). "Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database". JAMA Neurology. 79 (10): 1085–1086. doi:10.1001/jamaneurol.2022.2184. PMC 9361182. PMID 35939305.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Nakmode DD, Day CM, Song Y, Garg S (Mei 2023). "The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems". Pharmaceutics. 15 (5): 1503. doi:10.3390/pharmaceutics15051503. PMC 10223383. PMID 37242745.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Fabbri M, Barbosa R, Rascol O (April 2023). "Off-time Treatment Options for Parkinson's Disease". Neurol Ther. 12 (2): 391–424. doi:10.1007/s40120-022-00435-8. PMC 10043092. PMID 36633762.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R (Desember 2017). "Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease". Molecules. 23 (1): 40. doi:10.3390/molecules23010040. PMC 5943940. PMID 29295587.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M (Mei 2016). "Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology". Brain. 139 (Pt 5): 1325–1347. doi:10.1093/brain/aww050. PMC 5839596. PMID 27189581.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Webber HE, Lopez-Gamundi P, Stamatovich SN, de Wit H, Wardle MC (Januari 2021). "Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults". Neurosci Biobehav Rev. 120: 123–158. doi:10.1016/j.neubiorev.2020.11.004. PMC 7855845. PMID 33202256.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Zénon A, Devesse S, Olivier E (September 2016). "Dopamine Manipulation Affects Response Vigor Independently of Opportunity Cost". J Neurosci. 36 (37): 9516–9525. doi:10.1523/JNEUROSCI.4467-15.2016. PMC 6601940. PMID 27629704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS (Maret 2016). "Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration". The American Journal of Medicine. 129 (3): 292–8. doi:10.1016/j.amjmed.2015.10.015. PMC 4841631. PMID 26524704.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

api.semanticscholar.org

Ehringer H, Hornykiewicz O (Desember 1960). "[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]". Klinische Wochenschrift. 38 (24): 1236–9. doi:10.1007/BF01485901. PMID 13726012. S2CID 32896604.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
Hardebo JE, Owman C (Juli 1980). "Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface". Annals of Neurology. 8 (1): 1–31. doi:10.1002/ana.410080102. PMID 6105837. S2CID 22874032.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"Lasker Award". 1969. Diarsipkan dari asli tanggal 5 Januari 2016.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link), retrieved 1 April 2013
"Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)". ir.acorda.com (dalam bahasa Canadian English). Diarsipkan dari asli tanggal 27 Desember 2018. Diakses tanggal 14 Februari 2019.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
"Drugs@FDA: FDA-Approved Drugs". accessdata.fda.gov. Diarsipkan dari asli tanggal November 4, 2016. Diakses tanggal 28 September 2024.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)

webmd.com (Global: 2,056^th place; Indonesian: 872^nd place)

"Carbidopa-Levodopa Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD". www.webmd.com (dalam bahasa Inggris). Diakses tanggal 2023-11-16.

Levodopa (Indonesian Wikipedia)

acorda.com (Global: low place; Indonesian: low place)

ir.acorda.com

archive.org (Global: 6th place; Indonesian: 3rd place)

books.google.com (Global: 3rd place; Indonesian: 4th place)

doi.org (Global: 2nd place; Indonesian: 2nd place)

drugs.com (Global: 529th place; Indonesian: 177th place)

fda.gov (Global: 470th place; Indonesian: 343rd place)

accessdata.fda.gov

hdl.handle.net (Global: 66th place; Indonesian: 122nd place)

inbrija.com (Global: low place; Indonesian: low place)

laskerfoundation.org (Global: low place; Indonesian: low place)

nih.gov (Global: 5th place; Indonesian: 6th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 15th place; Indonesian: 26th place)

api.semanticscholar.org

web.archive.org (Global: 1st place; Indonesian: 1st place)

webmd.com (Global: 2,056th place; Indonesian: 872nd place)

archive.org (Global: 6^th place; Indonesian: 3^rd place)

books.google.com (Global: 3^rd place; Indonesian: 4^th place)

doi.org (Global: 2^nd place; Indonesian: 2^nd place)

drugs.com (Global: 529^th place; Indonesian: 177^th place)

fda.gov (Global: 470^th place; Indonesian: 343^rd place)

hdl.handle.net (Global: 66^th place; Indonesian: 122^nd place)

nih.gov (Global: 5^th place; Indonesian: 6^th place)

semanticscholar.org (Global: 15^th place; Indonesian: 26^th place)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

webmd.com (Global: 2,056^th place; Indonesian: 872^nd place)